Draft guidance from NICE (National Institute for Health and Care Excellence) has recommended Endomag’s Sentimag probe for the NHS.
Sentimag detects a magnetised liquid, Magtrace, which is injected into the tissue around the cancer. It tracks the fluid’s journey – bleeping as it moves over the skin – to show where cancer may have seeded. A surgeon can then sample or biopsy the region to check if cancer is present.
Over 160,000 women, in more than 600 hospitals have received a better standard of breast surgery thanks to Endomag’s technologies.
Read the full story from BBC here.